News & Events

CatSci opens new Dagenham laboratory dedicated to analytical excellence

CatSci opens new Dagenham laboratory dedicated to analytical excellence

Cardiff, UK – 8 June 2021 – CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development, has opened its new analytical science laboratory in Dagenham, UK with a focus on combining analytical and synthetic chemistry expertise and the latest high-end equipment to solve the industry’s current and future complex problems. The new facility will further cement the UK’s position as a centre for excellence in pharmaceutical research and development.

The new facility is fully equipped with state-of-the-art analytical equipment, through a collaboration with Shimadzu Corporation, providing the highest-quality analytical data and critical interpretation to customers and enabling them to rapidly reach the right decisions for their projects the first time, every time. A key early milestone in CatSci’s ambitious £3 million investment plan, this new dedicated analytical resource further positions CatSci as an innovation partner in medicines development that can add strategic value to customers, swiftly addressing their evolving CMC challenges and de-risking their pharmaceutical pipelines.

The demand for solving multi-disciplinary analytical problems is growing with the advent of new modalities and asset classes, such as oligonucleotides and cannabinoids. At the same time, new or modified regulatory requirements such as nitrosamine determinations and trace impurity analysis require the development of highly specific and sensitive methods.

Dr Ross Burn, CEO, said: “The opening of our analytical laboratory at LondonEast in Dagenham, UK is an exciting step on our journey towards becoming a fully integrated CMC company that accelerates medicine development to deliver best-in-class therapeutics to those in need. Solving complex challenges that our customers face is at the core of what we do and this new facility, filled with Shimadzu’s cutting-edge equipment, sets a new exemplary standard for measurement science in the industry.”

Dr Nigel Richardson, Director of Analytical Technology & New Modalities, added: “We’re excited to leverage our large pharma heritage across the CMC landscape and excellence in analytical science to work seamlessly with our customers to solve their analytical chemistry challenges with speed and scientific integrity.

“The opening of this new facility deepens the level of support we can offer. We will also be upgrading the site with capacity for GMP analytical development and testing, which will further increase our ability to provide innovative, tailored solutions from early development pre-clinical data packages to late development Phase III impurity fate studies.”

About CatSci

CatSci Ltd is an award-winning innovation partner for medicines development, dedicated to developing economically and environmentally sustainable pharmaceutical manufacturing processes. We proudly serve customers across the globe, meeting their needs from candidate selection to product launch and beyond. Our tailored services include route scouting and selection, initial scale-up and risk management for early development. For later development, we provide process design, assessment and optimisation, scale-up for clinical and commercial manufacture, tech transfer and post-approval improvements. We possess a range of critical enabling technologies including catalysis, material science and analytical development.

Agile, commercially-minded and scientifically-led, CatSci leverages its highly qualified technical team and state-of-the-art facilities to empower our customers to create affordable, best-in-class small molecule therapeutics in a safer, greener and more cost-effective way. Together, we can meet the evolving healthcare needs of the world.

CatSci works efficiently with your preferred partners, while continually strengthening our own industry-leading partnerships across the pharmaceutical supply chain, to address your dynamic drug substance development needs. A true extension of your team, we are a dependable, trusted partner for innovation that takes the time to understand your project objectives and provide you with perfect-for-purpose solutions.

Recognition includes wins at the prestigious CPhI Pharma Awards (Excellence in Pharma: Contract Services and Outsourcing), at the highly esteemed Cardiff Business Awards (International Business of the Year) and the Wales STEM 2020 Awards (STEM scale-up of the year). We were also recently shortlisted for the International Expansion Entrepreneur of the Year at the Barclays Entrepreneur Awards 2020 and the 2020 Bionow Export Award.

Follow us on Twitter and LinkedIn

For more information please contact:

back to news


Tim WatsonPartner